Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: I. Evaluation of the GTI QuikID assay and analysis of antibody patterns

Human Immunology

Volumn 62, Issue 3, 2001, Pages 228-235

  Zachary, Andrea A ^a   Delaney, Nancy L ^a   Lucas, Donna P ^a   Leffell, Mary S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ELISA; HLA antibody; Sensitivity; Specificity

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 0035076896     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00254-8     Document Type: Article

References (11)

1. Relevance of antibody screening and crossmatching in solid organ transplantation
2. HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure
3. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay
4. The basic lymphocyte microcytotoxicity test
5. HLA antibody screening: Comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocyto-toxicity
6. The occurrence of crossreactive "public" antibodies in the sera of highly sensitized dialysis patients
7. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants: Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation
8. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients
9. Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods
10. A novel approach to cost containment in the HLA laboratory
11. Characterization of HLA class I-specific antibodies using solubilized antigen targets: II. Clinical relevance